Given the financial summary answer the question below. Financial Summary 2019 2018 2017 As Adjusted (a) 2016
Fantastic news! We've Found the answer you've been seeking!
Question:
Transcribed Image Text:
Financial Summary 2019 2018 2017 As Adjusted (a) 2016 As Adjusted 2015 As Adjusted (b) FINANCIAL RESULTS (in millions) Sales (c) Other revenue Total revenue Cost of sales $77,130 982 $74,433 923 $71,786 $69,414 $73,717 928 857 777 78,112 75,356 72,714 70,271 74,494 54,864 53,299 51,125 49,145 52,241 Selling, general and administrative expenses (SG&A) 16,233 15,723 15,140 14,217 15,406 Depreciation and amortization (exclusive of depreciation included in cost of sales) 2,357 2,224 2,225 2,045 1,969 Operating income 4,658 4,110 4,224 4,864 4,878 Net interest expense (d) 477 461 653 991 607 Net other (income) / expense (e) (9) (27) (59) (88) (652) Earnings from continuing operations before income taxes 4,190 3,676 3,630 3,961 4,923 Provision for income taxes (f) Net earnings from continuing operations Discontinued operations, net of tax Net earnings PER SHARE Basic earnings per share Continuing operations Discontinued operations Net earnings per share Diluted earnings per share Continuing operations Discontinued operations Net earnings per share 921 746 722 1,295 1,602 3,269 2,930 2,908 2,666 3,321 12 7 6 68 42 $3,281 $2,937 $2,914 $2,734 $3,363 $6.39 $5.54 $5.32 $4.61 $5.29 0.02 0.01 0.01 0.12 0.07 $6.42 $5.55 $5.32 $4.73 $5.35 $6.34 $5.50 $5.29 $4.58 $5.25 0.02 0.01 0.01 0.12 0.07 $6.36 $5.51 $5.29 $4.69 $5.31 Cash dividends declared $2.62 $2.54 $2.46 $2.36 $2.20 FINANCIAL POSITION (in millions) Total assets $42,779 $41,290 $40,303 $38,724 $40,262 Capital expenditures $3,027 $3,516 $2,533 $1,547 $1,438 Long-term debt, including current portion $11,499 $11,275 $11,398 $12,591 $12,760 Net debt (g) $9,689 $10,506 $10,267 $11,481 $9,752 Shareholders' investment $11,833 $11,297 $11,651 $10,915 $12,957 FINANCIAL RATIOS Comparable sales growth (h) Gross margin (% of sales) SG&A (% of total revenue) Operating income margin (% of total revenue) 3.4% 5.0% 1.3% (0.5)% 2.1% 28.9% 28.4% 28.8% 29.2% 29.1% 20.8% 20.9% 20.8% 20.2% 20.7% 6.0% 5.5% 5.8% 6.9% 6.5% OTHER Common shares outstanding (in millions) 504.2 517.8 541.7 556.2 602.2 Operating cash flow provided by continuing operations (in millions) $7,099 $5,970 $6,861 $5,337 $5,254 Revenue per square foot (i) $326 $314 Retail square feet (in thousands) 240,516 239,581 Square footage growth 0.4% 0.1% Total number of stores Total number of distribution centers 1,868 42 1,844 40 $298 239,355 (0.1)% 1,822 $293 239,502 -% 1,802 $310 239,539 (0.2)% 1,792 41 40 40 (a) Consisted of 53 weeks. (b) The financial summary data for fiscal year 2015 does not reflect adoption of Accounting Standards Update (ASU) No. 2016-02-Leases (Topic 842). (c) The 2016 sales decline is primarily due to the December 2015 sale of our pharmacy and clinic businesses (Pharmacy Transaction) to CVS Pharmacy, Inc. 2015 sales includes $3,815 million related to our former pharmacy and clinic businesses. (d) Includes losses on early retirement of debt of $10 million, $123 million, and $422 million for 2019, 2017, and 2016, respectively. (e) For 2015, includes the gain on the sale of our pharmacy and clinic businesses. (f) For 2018 and 2017, includes $36 million and $343 million, respectively, of discrete tax benefits related to the Tax Cuts and Jobs Act of 2017. (g) Including current portion of long-term debt and other borrowings, net of short-term investments of $1,810 million, $769 million, $1,131 million, $1,110 million, and $3,008 million in 2019, 2018, 2017, 2016, and 2015, respectively. Management believes this measure is an indicator of our level of financial leverage because short-term investments are available to pay debt maturity obligations. For 2017 and earlier, only short-term investments held by U.S. entities were used to calculate net debt because amounts held by entities located outside the U.S. were restricted for use. (i) (h) See definition of comparable sales in Form 10-K, Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations. Represents revenue per square foot which is calculated using rolling four quarters average square feet. In 2017, revenue per square foot was calculated excluding the 53rd week in order to provide a more useful comparison to other years. Using total reported revenue for 2017 (including the 53rd week) resulted in revenue per square foot of $303. The 2016 decrease is primarily due to the Pharmacy Transaction. Our former pharmacy and clinic businesses contributed approximately $16 to 2015 revenue per square foot. Financial Summary 2019 2018 2017 As Adjusted (a) 2016 As Adjusted 2015 As Adjusted (b) FINANCIAL RESULTS (in millions) Sales (c) Other revenue Total revenue Cost of sales $77,130 982 $74,433 923 $71,786 $69,414 $73,717 928 857 777 78,112 75,356 72,714 70,271 74,494 54,864 53,299 51,125 49,145 52,241 Selling, general and administrative expenses (SG&A) 16,233 15,723 15,140 14,217 15,406 Depreciation and amortization (exclusive of depreciation included in cost of sales) 2,357 2,224 2,225 2,045 1,969 Operating income 4,658 4,110 4,224 4,864 4,878 Net interest expense (d) 477 461 653 991 607 Net other (income) / expense (e) (9) (27) (59) (88) (652) Earnings from continuing operations before income taxes 4,190 3,676 3,630 3,961 4,923 Provision for income taxes (f) Net earnings from continuing operations Discontinued operations, net of tax Net earnings PER SHARE Basic earnings per share Continuing operations Discontinued operations Net earnings per share Diluted earnings per share Continuing operations Discontinued operations Net earnings per share 921 746 722 1,295 1,602 3,269 2,930 2,908 2,666 3,321 12 7 6 68 42 $3,281 $2,937 $2,914 $2,734 $3,363 $6.39 $5.54 $5.32 $4.61 $5.29 0.02 0.01 0.01 0.12 0.07 $6.42 $5.55 $5.32 $4.73 $5.35 $6.34 $5.50 $5.29 $4.58 $5.25 0.02 0.01 0.01 0.12 0.07 $6.36 $5.51 $5.29 $4.69 $5.31 Cash dividends declared $2.62 $2.54 $2.46 $2.36 $2.20 FINANCIAL POSITION (in millions) Total assets $42,779 $41,290 $40,303 $38,724 $40,262 Capital expenditures $3,027 $3,516 $2,533 $1,547 $1,438 Long-term debt, including current portion $11,499 $11,275 $11,398 $12,591 $12,760 Net debt (g) $9,689 $10,506 $10,267 $11,481 $9,752 Shareholders' investment $11,833 $11,297 $11,651 $10,915 $12,957 FINANCIAL RATIOS Comparable sales growth (h) Gross margin (% of sales) SG&A (% of total revenue) Operating income margin (% of total revenue) 3.4% 5.0% 1.3% (0.5)% 2.1% 28.9% 28.4% 28.8% 29.2% 29.1% 20.8% 20.9% 20.8% 20.2% 20.7% 6.0% 5.5% 5.8% 6.9% 6.5% OTHER Common shares outstanding (in millions) 504.2 517.8 541.7 556.2 602.2 Operating cash flow provided by continuing operations (in millions) $7,099 $5,970 $6,861 $5,337 $5,254 Revenue per square foot (i) $326 $314 Retail square feet (in thousands) 240,516 239,581 Square footage growth 0.4% 0.1% Total number of stores Total number of distribution centers 1,868 42 1,844 40 $298 239,355 (0.1)% 1,822 $293 239,502 -% 1,802 $310 239,539 (0.2)% 1,792 41 40 40 (a) Consisted of 53 weeks. (b) The financial summary data for fiscal year 2015 does not reflect adoption of Accounting Standards Update (ASU) No. 2016-02-Leases (Topic 842). (c) The 2016 sales decline is primarily due to the December 2015 sale of our pharmacy and clinic businesses (Pharmacy Transaction) to CVS Pharmacy, Inc. 2015 sales includes $3,815 million related to our former pharmacy and clinic businesses. (d) Includes losses on early retirement of debt of $10 million, $123 million, and $422 million for 2019, 2017, and 2016, respectively. (e) For 2015, includes the gain on the sale of our pharmacy and clinic businesses. (f) For 2018 and 2017, includes $36 million and $343 million, respectively, of discrete tax benefits related to the Tax Cuts and Jobs Act of 2017. (g) Including current portion of long-term debt and other borrowings, net of short-term investments of $1,810 million, $769 million, $1,131 million, $1,110 million, and $3,008 million in 2019, 2018, 2017, 2016, and 2015, respectively. Management believes this measure is an indicator of our level of financial leverage because short-term investments are available to pay debt maturity obligations. For 2017 and earlier, only short-term investments held by U.S. entities were used to calculate net debt because amounts held by entities located outside the U.S. were restricted for use. (i) (h) See definition of comparable sales in Form 10-K, Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations. Represents revenue per square foot which is calculated using rolling four quarters average square feet. In 2017, revenue per square foot was calculated excluding the 53rd week in order to provide a more useful comparison to other years. Using total reported revenue for 2017 (including the 53rd week) resulted in revenue per square foot of $303. The 2016 decrease is primarily due to the Pharmacy Transaction. Our former pharmacy and clinic businesses contributed approximately $16 to 2015 revenue per square foot.
Expert Answer:
Posted Date:
Students also viewed these accounting questions
-
The part B of Figure 4.4, see Example 4.5, clearly shows the presence of outliers for the number of dead insects for insecticides C and D. Identify the outlying data points. Remove the outlying...
-
Use the attached "words.txt" file to store the words along with their ranks in an AVL tree. Then provide the user the option to search for any word. If the word exists the program displays the rank...
-
A teacher has just given an algebra exam. What are some of the statistics she could compute?
-
Write two equations for the AS curve. In both cases, assume that expectations are adaptive and that the effect of supply shocks is zero. For the first equation, assume that the inflation rate is very...
-
A current of 6 sin 4t A flows through a 2-F capacitor. Find the voltage v(t) across the capacitor given that v(0) = 1 V.
-
Stephen recognizes that there are different techniques for attracting attention to advertisements, and he wants to test three of these for the sample product: all color, all black-and-white, and a...
-
Information concerning Tully Corporations intangible assets is as follows: a. On January 1, 2007 Tully signed an agreement to operate as a franchisee of Rapid Copy Service, Inc., for an initial...
-
Choose a person who has been shunned from society. Tell why this person has been shunned from society, and how this person has been treated. Discuss how it would feel like to live as this person. How...
-
Leach Inc. experienced the following events for the first two years of its operations: Year 1: 1. Issued $10,000 of common stock for cash. 2. Provided $80,000 of services on account. 3. Provided...
-
A company pays the electric bill with cash. What entry is made in the journal?
-
From the video, Marketing Foundations: Influencer Marketing (2016): Unhappy Customers Links to an external site., answer the following questions: How does customer service impact customer lifetime...
-
Design Change at Cranfield Computer Technologies It was clear to Steve Owens, president and CEO of Cranfield Computer Technologies that the organizational structure of Cranfield Tech. was no longer...
-
Are leaders born or made? Leaders must guide, inspire, and influence others, but what are the key traits, styles, and behaviors allowing them to do so? This week we will dive into leadership...
-
Is leadership of a project different in an Agile environment than in a traditional project environment?
-
Read the case study Marc Inc and identify the cause of this problem in a strategic way
-
A woman at a point A on the shore of a circular lake with radius 2 mi wants to arrive at the point C diametrically opposite on the other side of the lake in the shortest possible A time. She can walk...
-
Following is a residual plot produced by MINITAB. Was it appropriate to compute the least-squares regression line? Explain. Residual -2 -3 1 2 3 5.0 5.5 09 6.0 Residuals Versus x 6.5 X 7.0 7.5 8.0
-
Following is a residual plot produced by MINITAB. Was it appropriate to compute the least-squares regression line? Explain. 50 50 Residuals Versus x 40 40 30 20 20 Residual 10 10 0 -10 -20 20 + -3 -2...
-
The following table presents the ages of the last 10 U.S. presidents and their wives on the first day of their presidencies. a. Compute the least-squares regression line for predicting the presidents...
Study smarter with the SolutionInn App